The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term results of a phase 2 trial of crenolanib combined with 7+3 chemotherapy in adults with newly diagnosed FLT3 mutant AML.
 
Eunice S. Wang
Consulting or Advisory Role - Abbvie; Astellas Pharma; Celgene/Bristol-Myers Squibb; Genentech; Gilead Sciences; GlaxoSmithKline; Jazz Pharmaceuticals; Kite/Gilead; Novartis; Pfizer; Pharmaessentia; PTC Therapeutics; Stemline Therapeutics; Takeda
Speakers' Bureau - Astellas Pharma; dava oncology; Kite, a Gilead company; Pfizer; Stemline Therapeutics
 
Aaron David Goldberg
Stock and Other Ownership Interests - Moderna Therapeutics; Novavax
Honoraria - Dava Oncology
Consulting or Advisory Role - Abbvie; Aptose Biosciences; Astellas Pharma; Celgene; Daiichi Sankyo; Genentech
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Aprea Therapeutics (Inst); Arog (Inst); Celularity (Inst); Pfizer (Inst); Trillium Therapeutics (Inst)
Travel, Accommodations, Expenses - Arog
 
Roland B. Walter
Stock and Other Ownership Interests - Amphivena Therapeutics
Consulting or Advisory Role - Agios; Amgen; Aptevo Therapeutics; Astellas Pharma; BiolineRx; Boston Biomedical; Bristol-Myers Squibb/Celgene/Juno; Daiichi Sankyo; Genentech; Janssen; Kite, a Gilead company; Kronos; Newlink Genetics; Pfizer; Race Oncology
Research Funding - Agios (Inst); Amgen (Inst); Aptevo Therapeutics; Arog (Inst); BiolineRx (Inst); Celgene; Immunogen (Inst); Janssen Research & Development (Inst); Jazz Pharmaceuticals (Inst); Kura Oncology; Macrogenics (Inst); Pfizer; Selvita (Inst)
 
Robert Collins
Employment - University of Texas Southwestern Medical Center - Simmons Cancer Center
Research Funding - Aeglea Biotherapeutics; Agios; Astellas Pharma; MedImmune; Oregon Health & Science University (OHSU)
 
Richard M. Stone
Honoraria - DAVA Pharmaceuticals; Medscape; Prime Oncology; Research to Practice
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; Aprea Therapeutics; Arog; Astellas Pharma; BerGenBio; Biolinerx; Boston Pharmaceuticals; Bristol Myers Squibb; Celgene; CTI BioPharma Corp; Daiichi-Sankyo; ElevateBio; Foghorn Therapeutics; Gemoab; GlaxoSmithKline; Innate Pharma; Janssen; Jazz Pharmaceuticals; Macrogenics; Novartis; Onconova Therapeutics; Syndax; Syntrix Biosystems; Syros Pharmaceuticals; Takeda; Trovagene
Research Funding - Abbvie/Genentech (Inst); Agios (Inst); Novartis (Inst)